-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Polyclonal light chains in cerebrovascular disease
Original Research
(1848) Views (429) Full article downloads
Authors: Patrizia Fiori, Maria Giannetti Luigi, Linda Iurato, et al
Published Date August 2010
Volume 2010:6(1) Pages 533 - 537
DOI: http://dx.doi.org/10.2147/NDT.S7529
Patrizia Fiori1, Maria Giannetti Luigi2, Linda Iurato1, Carminantonio Tammaro3, Gigliola Esposito3, Antonio Monaco11Central Operative Unit of Neurology (Dir. A Monaco), 2Infantile Neuropsychiatry and Social Service (Dir. LM Giannetti), 3Laboratory (Dir. CA Tammaro), ASL AV, Civil Hospital of Ariano Irpino, University of Naples, Italy
Abstract: Altered membrane permeability is a hallmark of inflammation and ischemia with systemic spreading. Renal dysfunction is a risk factor for cardiovascular, cerebrovascular, and metabolic diseases. The aim of the present study was to assess proteinuria and urinary polyclonal light chains in acute stroke and chronic cerebrovascular disease compared with other neurologic diseases. Our results showed significantly increased levels of urinary polyclonal light chains in cerebrovascular disease compared with other neurologic diseases. The highest values of urinary polyclonal κ chains were found in acute stroke compared with chronic cerebrovascular disease and other neurologic diseases, while the level of λ chains was mainly increased in chronic cerebrovascular diseases. The shift to chronic renal failure seems to be signaled by a decreased polyclonal light chain/creatinemia ratio. The absence of a significant correlation with blood pressure and other seric parameters suggests that polyclonal light chains are an early marker of reversible vascular impairment with renal dysfunction before progression to irreversible renal failure and need for dialysis and/or intensive care.
Keywords: polyclonal light chains, cerebrovascular disease, renal failure
Other articles by Dr Patrizia Fiori
Brief assessment of negative dysmorphic signs
Readers of this article also read:
Topiramate: the evidence for its therapeutic value in the prevention of migraine
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Management of depression in elderly stroke patients
Depression care and prevalence in HIV-positive individuals
Greater osteoblast and endothelial cell adhesion on nanostructured polyethylene and titanium
Brief assessment of negative dysmorphic signs
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
An improved delivery system for bladder irrigation
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference




